NCT00008008View on ClinicalTrials.gov

Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 1997

Primary Completion Date

June 30, 2005

Study Completion Date

May 31, 2008

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

sargramostim

DRUG

cyclophosphamide

DRUG

thiotepa

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (2)

10032

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York

07503

St. Joseph's Hospital and Medical Center, Paterson

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Herbert Irving Comprehensive Cancer Center

OTHER

NCT00008008 - Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma | Biotech Hunter | Biotech Hunter